Report Library
All Reports
New BioMedTracker Likelihood of Approval Rates
February 15, 2011
BioMedTracker and BIO today presented top-line results of a study analyzing clinical success rates at the 13th Annual BioCEO & Investor Conference. These rates were determined using BioMedTracker proprietary data from 2003 through 2010. The slide presentation is available by clicking on the PDF link above. BioMedTracker will be implementing these new average Likelihood of Approval (LOA) rates onto the website over the coming months.
For our disclosures, please read the BioMedTracker Research Standards.
| Indications Covered: |
Bipolar Disorder
Diabetes Mellitus, Type I Diabetes Mellitus, Type II Dry Age-Related Macular Degeneration (Dry AMD)/Geographic Atrophy Dyslipidemia / Hypercholesterolemia End-Stage Renal Disease (ESRD) Generalized Anxiety Disorder (GAD) Hepatitis C (HCV) Treatment HIV / AIDS Treatment Inflammatory Bowel Disease (IBD) Insomnia Multiple Myeloma (MM) Multiple Sclerosis (MS) Non-Hodgkin's Lymphoma (NHL) Non-Small Cell Lung Cancer (NSCLC) Obesity Osteoporosis / Osteopenia Pain Indications Rheumatoid Arthritis (RA) Stroke Prevention in Atrial Fibrillation (SPAF) Systemic Lupus Erythematosus (SLE) |